Omeros Corporation to Announce Third Quarter 2016 Financial Results on November 9, 2016

by Business Wire • 2016/11/07 • 0 Comments

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system, today announced that the company will issue its third quarter 2016 financial results for the period ended September 30, 2016, on Wednesday, November 9, 2016, after the market cl

← Global Glaucoma Treatment Options, Attributes, Market Positioning, Reimbursement Landscape & New Drug Pricing Report 2012-2021 – Research and Markets

Genetic mutations that lead to macular degeneration blindness mapped by new research →

Post navigation